Skip to main content
. 2012 Apr 13;7(4):e35012. doi: 10.1371/journal.pone.0035012

Figure 3. Molecular pathways modulated in response to treatment with aleglitazar, tesaglitazar or Pio/Feno.

Figure 3

Number of RNA expression changes observed following treatment with aleglitazar, tesaglitazar or Pio/Feno. Of the 2,000 unique mechanisms represented in the knowledgebase, 280 were considered statistically significant in at least one treatment condition and are designated as “hypotheses”.